2020 was an unusual year mainly due to the global COVID-19 pandemic, which caused a 27% decrease in the global dental bone graft substitute (DBGS) and other biomaterials market from 2019 to 2020. Following the closure of non-essential businesses in Q1 and much of Q2 2020, the dental implant and bone graft substitute markets began to show strong signs of recovery in certain regions throughout Q3 as dentists began working through the backlog of pent-up demand. Luckily for this market, demographic factors are a major driver of the global dental bone graft substitute and biomaterials market. DBGS and dental membrane products are used commonly in dental implant procedures. As the global population continues to grow and age, the demand for implant procedures is expected to increase.
WHAT SEGMENTS ARE IN THE GLOBAL DENTAL BONE GRAFT SUBSTITUTE MARKET?
iData’s market report on the global dental bone graft substitute (DBGS) market includes:
Autografts are bone graft materials taken from the patient’s own body. Autograft harvesting involves the transplantation of the patient’s bone or tissue to the affected area of their body. Usually, dental autografts are extracted from the jawbone to restrict the operation to one area of the body. However, if a large volume of autograft material is required, tissue can be harvested from other parts of the body, such as the hip.
Allografts are bone graft material taken from human donors. They are processed by tissue banks to eliminate the risk of disease transmission and improve handling characteristics. During these treatments, the original allograft material is frozen, screened, sterilized, gamma irradiated and/or acid washed.
Demineralized Bone Matrix Allografts
Demineralized bone matrix (DBM) material is a special type of allograft. This category includes demineralized freeze-dried bone allografts, either with or without a carrier.DBM materials have a far lower risk of disease transmission than mineralized allografts because of the extra processing involved in their preparation.
Xenograft materials are BGS derived from another species. In dentistry, bovine bone is the most common source of xenograft materials. It is easy to harvest large volumes of bovine bone material. Supply is plentiful. Xenograft materials are now also being derived from porcine and equine materials, as well.
Synthetic materials are the only type of BGS that do not come from human or animal bone. Synthetic materials pose no risk for disease transmission and are not harvested from patients. However, results with synthetic materials have not been as positive as those with allografts. Such results have led to a decline in their popularity.
Artificial dental membranes are used during bone grafting procedures to allow the bone to regenerate without the in-growth of soft tissue (gingival) cells. There are two types of dental membranes: non-resorbable and resorbable. Non-resorbable membranes must be removed in a separate procedure after the healing process is complete. However, resorbable membranes break down after a period of time and are absorbed, eliminating the need for a second procedure.
WHICH COMPANIES COMPETE IN THE DENTAL BONE GRAFT SUBSTITUTE MARKET?
The top three competitors are Geistlich, Zimmer Biomet, and ACE Surgical.
Geistlich was the leading competitor in the global DBGS and dental biomaterials market. The company generated most of its revenue from the DBGS market, but it also held the leading position in the dental membrane market. Within the DBGS market, the company’s strong position was a direct result of its leading presence in the xenograft segment.
Zimmer Biomet was the second-leading competitor in the global DBGS and dental biomaterials market in 2020. The company was formed through the merger of Zimmer and Biomet in June 2015, combining the dental divisions of each company, Zimmer Dental and BIOMET 3i. The company continues to maintain a strong presence in the overall DBGS market by providing products in all of the sub-segments of the market.
ACE Surgical held the third-leading position in the global dental bone graft substitute and dental membrane market in 2020. The company offered products in both the allograft and xenograft segments for DBGS, and sells both resorbable and non-resorbable membranes. The company is one of the few dental distributors that offers regenerative materials in its product portfolio.
GLOBAL DENTAL BONE GRAFT SUBSTITUTE MARKET RECAP AND FURTHER INSIGHTS
For more information on unit sales, average selling prices (ASPs), competitive analyses, and more, follow the link below to receive a free market synopsis for the global dental bone graft substitute market. Additionally, iData offers updated 2021 DBGS reports for the following regions: Asia-Pacific (Australia, China, India, Japan, South Korea), Latin America (Argentina, Brazil, Mexico), United States, and Europe.